Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
J Clin Oncol
; 36(3): 276-282, 2018 01 20.
Article
in En
| MEDLINE
| ID: mdl-29182496
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Pyrimidines
/
Bile Duct Neoplasms
/
Biomarkers, Tumor
/
Cholangiocarcinoma
/
Protein Kinase Inhibitors
/
Receptor, Fibroblast Growth Factor, Type 2
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
2018
Document type:
Article
Country of publication:
Estados Unidos